{"nct_id":"NCT06307431","title":"A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2024-04-10","start_date_type":"ACTUAL","primary_completion_date":"2028-01-08","primary_completion_date_type":"ESTIMATED","completion_date":"2032-06-08","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}